151 related articles for article (PubMed ID: 38627705)
21. Safety and Efficacy of YAG Laser Vitreolysis for the Treatment of Vitreous Floaters: An Overview.
Katsanos A; Tsaldari N; Gorgoli K; Lalos F; Stefaniotou M; Asproudis I
Adv Ther; 2020 Apr; 37(4):1319-1327. PubMed ID: 32086749
[TBL] [Abstract][Full Text] [Related]
22. [Vitreolysis with Nd:YAG laser].
Gao YB
Zhonghua Yan Ke Za Zhi; 1990 Nov; 26(6):352-4. PubMed ID: 2086156
[TBL] [Abstract][Full Text] [Related]
23. [Vitreous floaters].
Schmitz-Valckenberg S; Brasse K; Hoerauf H
Ophthalmologe; 2020 May; 117(5):485-496. PubMed ID: 32291480
[TBL] [Abstract][Full Text] [Related]
24. Q-switched neodymium: YAG laser surgery of the vitreous.
Little HL; Jack RL
Graefes Arch Clin Exp Ophthalmol; 1986; 224(3):240-6. PubMed ID: 3754829
[TBL] [Abstract][Full Text] [Related]
25. Novel OCT Application and Optimized YAG Laser Enable Visualization and Treatment of Mid- to Posterior Vitreous Floaters.
Singh IP
Ophthalmic Surg Lasers Imaging Retina; 2018 Oct; 49(10):806-811. PubMed ID: 30395668
[TBL] [Abstract][Full Text] [Related]
26. Bilateral posterior capsule injury after Nd:YAG laser vitreolysis: unintended consequence of floaters treatment.
O'Day R; Cugley D; Chen C; Fabinyi D
Clin Exp Ophthalmol; 2018 Nov; 46(8):956-958. PubMed ID: 29573082
[No Abstract] [Full Text] [Related]
27. Eligibility criteria for Nd-YAG laser treatment of highly symptomatic vitreous floaters.
Vandorselaer T; Van De Velde F; Tassignon MJ
Bull Soc Belge Ophtalmol; 2001; (280):15-9. PubMed ID: 11486460
[TBL] [Abstract][Full Text] [Related]
28. Long-term evaluation of the efficacy and safety of Nd:YAG laser vitreolysis for symptomatic vitreous foaters.
Nunes GM; Ludwig GD; Gemelli H; Zanotele M; Serracarbassa PD
Arq Bras Oftalmol; 2022; 87(2):0395. PubMed ID: 36169439
[TBL] [Abstract][Full Text] [Related]
29. Long-term efficacy and safety of YAG laser vitreolysis for vision degrading myodesopsia.
Lin TZ; Shi C; Yang X; Eric Pazo E; Hui YN; Shen LJ
Int J Ophthalmol; 2023; 16(11):1800-1805. PubMed ID: 38028528
[TBL] [Abstract][Full Text] [Related]
30. Objective assessment of YAG laser vitreolysis in patients with symptomatic vitreous floaters.
Souza CE; Lima LH; Nascimento H; Zett C; Belfort R
Int J Retina Vitreous; 2020; 6():1. PubMed ID: 31988795
[TBL] [Abstract][Full Text] [Related]
31. Application of Nd:YAG laser to the anterior vitreous in malignant glaucoma - a systemic review and meta-analysis.
Safir M; Hecht I; Sharon T; Einan-Lifshitz A; Belkin A
Graefes Arch Clin Exp Ophthalmol; 2022 Sep; 260(9):2981-2990. PubMed ID: 35348842
[TBL] [Abstract][Full Text] [Related]
32. Iatrogenic Vitreous Hemorrhage, Subretinal Hemorrhage, and Branch Retinal Vein Occlusion after YAG Laser Vitreolysis for Symptomatic Vitreous Floaters.
Shields RA; Cheng OT; Wolfe JD
Ophthalmology; 2021 Apr; 128(4):616. PubMed ID: 33745529
[No Abstract] [Full Text] [Related]
33. Cataract formation after YAG laser vitreolysis: importance of femtosecond laser anterior capsulotomies in perforated posterior capsules.
Noristani R; Schultz T; Dick HB
Eur J Ophthalmol; 2016 Nov; 26(6):e149-e151. PubMed ID: 27646329
[TBL] [Abstract][Full Text] [Related]
34. [Results of YAG-laser vitreolysis in proliferative diabetic retinopathy complicated by vitreous hemorrhage].
Kasimov ÉM; Alieva NI; Mamedzade AN
Vestn Oftalmol; 2014; 130(4):22-6. PubMed ID: 25306719
[TBL] [Abstract][Full Text] [Related]
35. Nd:YAG vitreolysis as a treatment for vitreous floaters.
Gandhi JS
Eye (Lond); 2003 Jan; 17(1):113; author reply 113. PubMed ID: 12579192
[No Abstract] [Full Text] [Related]
36. Reported Complications Following Laser Vitreolysis.
Hahn P; Schneider EW; Tabandeh H; Wong RW; Emerson GG;
JAMA Ophthalmol; 2017 Sep; 135(9):973-976. PubMed ID: 28750116
[TBL] [Abstract][Full Text] [Related]
37. The Efficacy and Safety of YAG Laser Vitreolysis for Symptomatic Vitreous Floaters of Complete PVD or Non-PVD.
Lin T; Li T; Zhang X; Hui Y; Moutari S; Pazo EE; Dai G; Shen L
Ophthalmol Ther; 2022 Feb; 11(1):201-214. PubMed ID: 34778916
[TBL] [Abstract][Full Text] [Related]
38. Triamcinolone-assisted neodymium:YAG laser vitreolysis.
Hosseini H; Mehryar M; Farvardin M
Ophthalmic Surg Lasers Imaging; 2008; 39(3):234-6. PubMed ID: 18556949
[TBL] [Abstract][Full Text] [Related]
39. Clinical experience with Nd:YAG laser vitreolysis in the anterior segment.
Levy JH; Pisacano AM
J Cataract Refract Surg; 1987 Sep; 13(5):548-50. PubMed ID: 3668839
[TBL] [Abstract][Full Text] [Related]
40. Effects of Nd-Yag laser vitreolysis on lens and vitreous prostaglandins in the rabbit eye.
Reibaldi A; Spampinato D; Cavaliere S; Rapisarda E; Cavallaro N; Caruso P; Dal Bello A; Drago F
Metab Pediatr Syst Ophthalmol (1985); 1991; 14(2):44-6. PubMed ID: 1369644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
